4.6 Article

An Implementation-Effectiveness Study of a Perioperative Delirium Prevention Initiative for Older Adults

Journal

ANESTHESIA AND ANALGESIA
Volume 131, Issue 6, Pages 1911-1922

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1213/ANE.0000000000005223

Keywords

-

Categories

Funding

  1. National Institute on Aging of the National Institutes of Health [91511, R24AG054259]
  2. University of California, San Francisco Clinical and Translational Science Institute Pilot Awards Program
  3. National Institutes of Health [UL1 TR991872]
  4. University of California Office of the President (UCOP) CRCC Award
  5. Awards for the HBCU Initiative
  6. National Institute on Aging [NIA R01 AG044425, NIA P30 AG04428, NIA R21AG054208, R03AG059822]
  7. Center for Disease Control [CDC-OPOIOIDS-2017-001, CDC-STEADI-2016-001]
  8. Sara & Evan Williams Foundation Endowed Neurohospitalist Chair
  9. Foundation for Anesthesia Education and Research
  10. National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) [UL1 TR991872]
  11. National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant [UL1TR001872]

Ask authors/readers for more resources

BACKGROUND: Postoperative delirium is a common and serious problem for older adults. To better align local practices with delirium prevention consensus guidelines, we implemented a 5-component intervention followed by a quality improvement (QI) project at our institution. METHODS: This hybrid implementation-effectiveness study took place at 2 adult hospitals within a tertiary care academic health care system. We implemented a 5-component intervention: preoperative delirium risk stratification, multidisciplinary education, written memory aids, delirium prevention postanesthesia care unit (PACU) orderset, and electronic health record enhancements between December 1, 2017 and June 30, 2018. This was followed by a department-wide QI project to increase uptake of the intervention from July 1, 2018 to June 30, 2019. We tracked process outcomes during the QI period, including frequency of preoperative delirium risk screening, percentage of high-risk screens, and frequency of appropriate PACU orderset use. We measured practice change after the interventions using interrupted time series analysis of perioperative medication prescribing practices during baseline (December 1, 2016 to November 30, 2017), intervention (December 1, 2017 to June 30, 2018), and QI (July 1, 2018 to June 30, 2019) periods. Participants were consecutive older patients (>= 65 years of age) who underwent surgery during the above timeframes and received care in the PACU, compared to a concurrent control group <65 years of age. The a priori primary outcome was a composite of perioperative American Geriatrics Society Beers Criteria for Potentially Inappropriate Medication Use (Beers PIM) medications. The secondary outcome, delirium incidence, was measured in the subset of older patients who were admitted to the hospital for at least 1 night. RESULTS: During the 12-month QI period, preoperative delirium risk stratification improved from 67% (714 of 1068 patients) in month 1 to 83% in month 12 (776 of 931 patients). Forty percent of patients were stratified as high risk during the 12-month period (4246 of 10,494 patients). Appropriate PACU orderset use in high-risk patients increased from 19% in month 1 to 85% in month 12. We analyzed medication use in 7212, 4416, and 8311 PACU care episodes during the baseline, intervention, and QI periods, respectively. Beers PIM administration decreased from 33% to 27% to 23% during the 3 time periods, with adjusted odds ratio (aOR) 0.97 (95% confidence interval [CI], 0.95-0.998; P = .03) per month during the QI period in comparison to baseline. Delirium incidence was 7.5%, 9.2%, and 8.5% during the 3 time periods with aOR of delirium of 0.98 (95% CI, 0.91-1.05, P = .52) per month during the QI period in comparison to baseline. CONCLUSIONS: A perioperative delirium prevention intervention was associated with reduced administration of Beers PIMs to older adults.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available